Hyperacmotone A alleviates Non-alcoholic Steatohepatitis via regulating PPARα signaling
{{output}}
Background: Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease (NAFLD), which is often accompanied by lipid metabolism disorders and mitochondrial dysfunction. Peroxisome proliferator-... ...
